AMETEK Engineered Medical Components (EMC)
Garry Wexler is a seasoned business development manager with extensive experience in the engineering and electronics sectors. Currently serving as the Business Development Manager at AMETEK Engineered Medical Components since April 2024, Garry previously held the same position at TCLAD INC. from May 2021 to March 2024. Prior to that, Garry worked at Henkel Electronic Materials LLC, where roles included Business Development Manager and Field Applications Engineer from December 2014 to April 2021. Garry's engineering background includes various positions at The Bergquist Company, encompassing field applications, technical sales, and product engineering roles over a 15-year span. Garry holds a Bachelor's degree in Chemical Engineering from the University of Minnesota, completed in 1999, and is a graduate of Apple Valley High School, class of 1994.
This person is not in any teams
AMETEK Engineered Medical Components (EMC)
Ametek Engineered Medical Components partners with the world’s top medical device manufacturers to design and manufacture state-of-the-art technology solutions for virtually every clinical application. Ametek Engineered Medical Components is a Division of Ametek, Inc., a leading global manufacturer of electronic instruments and electromechanical devices. Our broad array of design and manufacturing capabilities includes custom engineered interconnects, catheter components and systems, implanted lead components, ultrasound assemblies, and precision laser machining services. The source of Ametek Engineered Medical Components expertise is the result of the merger of two of the world’s top providers of medical technology design, manufacturing and logistics (Avicenna and TSE Inc). Our world-class team has a reputation for uncompromising quality and a commitment to complete customer satisfaction. AMETEK Engineered Medical Components is a Division of AMETEK, Inc., a leading global manufacturer of electronic instruments and electromechanical devices with sales near $4.0 billion.